New Studies Give Hope to Parkinson's Patients

Gene therapy, drug could halt disease
By Colleen Barry,  Newser Staff
Posted Jun 22, 2007 4:25 AM CDT
New Studies Give Hope to Parkinson's Patients
Nathan Klein of Port Washington, N.Y., left, poses for a portrait with Dr. Michael Kaplitt, of Weill Cornell Medical College, Thursday, June 21, 2007, in New York. Klein, a 59-year-old freelance television producer, was the first Parkinson's patient to be treated with a gene therapy procedure in 2003....   (Associated Press)

Two new experimental treatments for Parkinson's could stop the progress of the devastating disease and allay its symptoms, researchers say. A new study shows gene therapy was successful in boosting production of an enzyme that calms overactive neurons, reducing the jittery effects of the brain disorder.

In a separate study, a new drug shielded fruit-fly neurons from a destructive Parkinson's enzyme. Researchers say the gene therapy had no side effects and staved off symptoms for as long as four years. Neither treatment is a cure, however, and both are a long way from FDA approval: Docs only tested gene therapy on 11 patients, while the drug hasn't been given to a single human. (Read more health stories.)

We use cookies. By Clicking "OK" or any content on this site, you agree to allow cookies to be placed. Read more in our privacy policy.
Get the news faster.
Tap to install our app.
Install the Newser News app
in two easy steps:
1. Tap in your navigation bar.
2. Tap to Add to Home Screen.